0000891293-19-000002.txt : 20190103
0000891293-19-000002.hdr.sgml : 20190103
20190103163110
ACCESSION NUMBER: 0000891293-19-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SEELEY BRUCE J.
CENTRAL INDEX KEY: 0001474462
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28386
FILM NUMBER: 19506003
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-31
0
0000891293
CTI BIOPHARMA CORP
ctic
0001474462
SEELEY BRUCE J.
3101 WESTERN AVENUE
SUITE 800
SEATTLE
WA
98121
0
1
0
0
EVP, Chief Operating Officer
Common Stock
2018-12-31
4
A
0
500
0.6236
A
32000
D
Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
Bruce J. Seeley
2018-12-31